Dr Lalchandani Labs Ltd (DLCL) — Stock Analysis

Dr Lalchandani Labs Ltd (NSE: DLCL), ISIN INE871Z01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

DLCL last traded at ₹7.41 (-4.88%), with a 52-week range of ₹6.46 to ₹21.21 (as of 30 Jul 2026).

Shareholding as of Sep 2025: promoters 31.15%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.

EquiSense Score (ECS): 66/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.